Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients

Background— Inflammation in adipose tissue has been implicated in vascular dysfunction, but the local mechanisms by which this occurs are unknown. Methods and Results— Small arteries with and without perivascular adipose tissue were taken from subcutaneous gluteal fat biopsy samples and studied with wire myography and immunohistochemistry. We established that healthy adipose tissue around human small arteries secretes factors that influence vasodilation by increasing nitric oxide bioavailability. However, in perivascular fat from obese subjects with metabolic syndrome (waist circumference 111±2.8 versus 91.1±3.5 cm in control subjects, P<0.001; insulin sensitivity 41±5.9% versus 121±18.6% in control subjects, P<0.001), the loss of this dilator effect was accompanied by an increase in adipocyte area (1786±346 versus 673±60 &mgr;m2, P<0.01) and immunohistochemical evidence of inflammation (tumor necrosis factor receptor 1 12.4±1.1% versus 6.7±1%, P<0.001). Application of the cytokines tumor necrosis factor receptor-&agr; and interleukin-6 to perivascular fat around healthy blood vessels reduced dilator activity, resulting in the obese phenotype. These effects could be reversed with free radical scavengers or cytokine antagonists. Similarly, induction of hypoxia stimulated inflammation and resulted in loss of anticontractile capacity, which could be rescued by catalase and superoxide dismutase or cytokine antagonists. Incubation with a soluble fragment of adiponectin type 1 receptor or inhibition of nitric oxide synthase blocked the vasodilator effect of healthy perivascular adipose tissue. Conclusions— We conclude that adipocytes secrete adiponectin and provide the first functional evidence that it is a physiological modulator of local vascular tone by increasing nitric oxide bioavailability. This capacity is lost in obesity by the development of adipocyte hypertrophy, leading to hypoxia, inflammation, and oxidative stress.

[1]  L. Cassis,et al.  Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.

[2]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Jenkins,et al.  Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. , 2005, American journal of physiology. Endocrinology and metabolism.

[4]  Bohan Wang,et al.  Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? , 2008, British Journal of Nutrition.

[5]  Arya M. Sharma,et al.  Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. , 2005, The Journal of thoracic and cardiovascular surgery.

[6]  H. Hauner,et al.  The Two Tumor Necrosis Factor Receptors Mediate opposite Effects on Differentiation and Glucose Metabolism in Human Adipocytes in Primary Culture* , 1999 .

[7]  E. Chung,et al.  Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial , 2003, Circulation.

[8]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[9]  D. Levy,et al.  Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. , 2008, The American journal of cardiology.

[10]  A. Vaag,et al.  Metabolic and Vascular Effects of Tumor Necrosis Factor-α Blockade with Etanercept in Obese Patients with Type 2 Diabetes , 2005, Journal of Vascular Research.

[11]  I. Laing,et al.  Age‐related increase in haemoglobin A1c and fasting plasma glucose is accompanied by a decrease in β cell function without change in insulin sensitivity: evidence from a cross‐sectional study of hospital personnel , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[12]  A. Hughes,et al.  Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. , 2003, British journal of pharmacology.

[13]  R. M. Lee,et al.  Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide , 2007, British journal of pharmacology.

[14]  C. Stehouwer,et al.  Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  A. Xu,et al.  Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. , 2006, Biochemical and biophysical research communications.

[16]  S. Haffner.  Abdominal adiposity and cardiometabolic risk: do we have all the answers? , 2007, The American journal of medicine.

[17]  P. Scherer,et al.  Adiponectin, Cardiovascular Function, and Hypertension , 2008, Hypertension.

[18]  M. Gollasch,et al.  Adiponectin is a novel humoral vasodilator. , 2007, Cardiovascular research.

[19]  M. Gollasch,et al.  Mechanisms of ADRF release from rat aortic adventitial adipose tissue. , 2004, American journal of physiology. Heart and circulatory physiology.

[20]  L. Lind,et al.  Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. , 1993, American heart journal.

[21]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[22]  M. Gollasch,et al.  Periadventitial fat releases a vascular relaxing factor , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[24]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[25]  Yu-Jing Gao,et al.  Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophy-related vascular dysfunction. , 2007, Current pharmaceutical design.

[26]  Philip A Kern,et al.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. , 2003, Diabetes.

[27]  K. Golba,et al.  Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  M. Mulvany,et al.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.

[29]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[30]  J. Jenkins,et al.  Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α , 2005 .

[31]  W. Halpern,et al.  Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system , 2006, Annals of Biomedical Engineering.

[32]  M. Gollasch,et al.  Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. , 2004, Trends in pharmacological sciences.

[33]  C. Stehouwer,et al.  “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.

[34]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[35]  R. Wimalasundera,et al.  Effect of tumour necrosis factor‐α and interleukin 1β on endothelium‐dependent relaxation in rat mesenteric resistance arteries in vitro , 2003 .

[36]  H. Hauner,et al.  Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non‐insulin‐dependent diabetes mellitus , 1999, European journal of clinical investigation.

[37]  M. Gollasch,et al.  Visceral Periadventitial Adipose Tissue Regulates Arterial Tone of Mesenteric Arteries , 2004, Hypertension.

[38]  G. Winkler,et al.  Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. , 2003, European journal of endocrinology.

[39]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.